Product Program year 2020 Source: CMS Open Payments

OptiSense Pacing Lead

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$1,458

29 payments

Research payments

$0

0 payments

Through program year 2020, $1,458 in general payments and $0 in research payments were reported against OptiSense Pacing Lead (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $749 15
2019 General $709 14

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $1,458 29 payments
Top recipients General payments · program year 2020
  1. Alberto Interian Cardiovascular Disease · Miami, FL $154 21% · 1 payment
  2. Adam Budzikowski Clinical Cardiac Electrophysiology · Brooklyn, NY $142 19% · 1 payment
  3. Sven Ender Clinical Cardiac Electrophysiology · Annapolis, MD $73 10% · 1 payment
  4. Walter Pinedo Cardiovascular Disease · Aguada, PR $64 9% · 1 payment
  5. Alexander Chernobelsky Cardiovascular Disease · Wellington, FL $64 9% · 1 payment

The top 5 of 15 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $370 49% · 6 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $258 34% · 4 practitioners
  3. Family Medicine $75 10% · 2 practitioners
  4. Internal Medicine $43 6% · 2 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $3 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Florida $296 39% · 5 recipients
  2. New York $155 21% · 2 recipients
  3. California $142 19% · 4 recipients
  4. Maryland $73 10% · 1 recipient
  5. Texas $60 8% · 2 recipients

The top 5 of 6 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

29 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record